DiaMedica Therapeutics In...

NASDAQ: DMAC · Real-Time Price · USD
6.03
0.02 (0.33%)
At close: Aug 15, 2025, 3:59 PM
6.03
0.08%
After-hours: Aug 15, 2025, 04:10 PM EDT

DiaMedica Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-24.44M -19.38M -13.68M -13.59M
Depreciation & Amortization
39K 30K 25K 24K
Stock-Based Compensation
2.08M 1.68M 1.5M 1.56M
Other Working Capital
1.36M 188K 312K 129K
Other Non-Cash Items
-1.27M -1.15M 53K 58K
Deferred Income Tax
n/a n/a n/a 161K
Change in Working Capital
1.51M 93K 585K -461K
Operating Cash Flow
-22.08M -18.73M -11.51M -12.25M
Capital Expenditures
-25K -24K -81K -22K
Cash Acquisitions
n/a n/a -11.62K 2K
Purchase of Investments
-50.41M -69.41M -45.68M -69.81M
Sales Maturities Of Investments
59M 51.13M 57.3M 49.3M
Other Investing Acitivies
n/a n/a 11.62K n/a
Investing Cash Flow
8.56M -18.3M 11.54M -20.54M
Debt Repayment
-9K -6K -6K -6K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
256K n/a n/a 244K
Financial Cash Flow
11.99M 36.84M -6K 30.09M
Net Cash Flow
-1.52M -185K 21K -2.7M
Free Cash Flow
-22.1M -18.75M -11.59M -12.27M